最新公告:

  没有公告

您现在的位置: 心灵之窗-眼科医生网 >> 眼科常识 >> 第11届全国会 >> 眼底病11 >> 正文
专题栏目
更多内容
相关文章
更多内容
Functional Restitutio ad Integrum By Intravitreal Bevacizumab for Exudative Age-Related Macular Degeneration         
Functional Restitutio ad Integrum By Intravitreal Bevacizumab for Exudative Age-Related Macular Degeneration
作者:Jost B. … 文章来源:Department of Ophthalmology, Faculty of Clinical Medicine Mannheim of the University Heidelberg, Germany 点击数:3355 更新时间:2006/7/10 20:27:37
Purpose. To report on a functional restitutio ad integrum after treatment of exudative age-related macular degeneration. Design. Interventional case report. Methods. A 70-year old patient received an intravitreal injection of 1.5 mg bevacizumab as treatment of a retinal pigment epithelium detachment due to age-related macular degeneration. Results. After the intravitreal bevacizumab application, visual acuity increased from 20/125 to 20/20, parallel to a resolution of subfoveal fluid as shown by optical coherence tomography. Ten weeks after the injection, the patient experienced an increase in metamorphopsias, and optical coherence tomography revealed a re-increase of macular edema. Visual acuity declined slightly to 20/25. After a second intravitreal bevacizumab injection (1.5 mg), metamorphopsias regressed and optical coherence tomography demonstrated further resolution of the subfoveal fluid. At the end of follow-up, visual acuity was 20/20. Conclusions. Repeated intravitreal injections of bevacizumab may lead to a complete and temporary restoration of visual acuity.
会议投稿录入:毛进    责任编辑:毛进 
  • 上一篇会议投稿:

  • 下一篇会议投稿:
  • 【字体: 】【发表评论】【加入收藏】【告诉好友】【打印此文】【关闭窗口
      网友评论:(只显示最新10条。评论内容只代表网友观点,与本站立场无关!)

    | 设为首页 | 加入收藏 | 联系站长 | 友情链接 | 版权申明 |
    眼科医生网 眼科医生网版权所有 @ 1998-2012
    部分文章和资源来源于网络,如果侵犯了您的版权,请指出! 站长:毛进
    信息产业部备案
    *京ICP备18030162号